Variants of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) with rapidly progressive course

被引：0
|
作者：
Tan, V.
Merriman, R.
Ferrell, L.
机构：
[1] Univ Calif San Francisco, San Francisco, CA 94143 USA
[2] Calif Pacific Med Ctr, San Francisco, CA USA
来源：
LABORATORY INVESTIGATION | 2008年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
1444
引用
收藏
页码：317A / 317A
页数：1
相关论文
共 50 条
  • [41] Nonalcoholic Fatty Liver disease (NAFLD)
    Zeuzem, S.
    Trautwein, C.
    [J]. GASTROENTEROLOGE, 2020, 15 (02): : 77 - 77
  • [42] NONALCOHOLIC FATTY LIVER DISEASE AND STEATOHEPATITIS
    Colak, Yasar
    Tuncer, Ilyas
    [J]. JOURNAL OF ISTANBUL FACULTY OF MEDICINE-ISTANBUL TIP FAKULTESI DERGISI, 2010, 73 (03): : 85 - 91
  • [43] High Risk of Mortality and Disease Progression Associated with Diabetes Mellitus (DM) and Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis (NAFLD/NASH) in Medicare Patients
    Loomba, Rohit
    Fraysse, Jeremy
    Li, Suying
    Ozbay, A. Burak
    [J]. DIABETES, 2019, 68
  • [44] Considerations for Physiologically Based Modeling in Liver Disease: From Nonalcoholic Fatty Liver (NAFL) to Nonalcoholic Steatohepatitis (NASH)
    Murphy, William A.
    Adiwidjaja, Jeffry
    Sjostedt, Noora
    Yang, Kyunghee
    Beaudoin, James J.
    Spires, Jessica
    Siler, Scott Q.
    Neuhoff, Sibylle
    Brouwer, Kim L. R.
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 113 (02) : 275 - 297
  • [45] Clinical Utility of a Noninvasive Metabolic Approach in Assessing the Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) in Type 2 Diabetes
    Bellido, Virginia
    Martinez-Arranz, Ibon
    Goicolea, Ignacio
    Amor, Antonio J.
    Pi, Javier
    Perez, Antonio
    Espiga, Javier
    Montalban, Coral
    Mayo, Rebeca
    Gaztambide, Sonia
    [J]. DIABETES, 2020, 69
  • [46] MRE-based NASH score for diagnosis of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease
    Young-Sun Lee
    Ji Eun Lee
    Hyon-Seung Yi
    Young Kul Jung
    Dae Won Jun
    Ji Hoon Kim
    Yeon Seok Seo
    Hyung Joon Yim
    Baek-hui Kim
    Jeong Woo Kim
    Chang Hee Lee
    Jong Eun Yeon
    Juneyoung Lee
    Soon Ho Um
    Kwan Soo Byun
    [J]. Hepatology International, 2022, 16 : 316 - 324
  • [47] Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis and Hepatocellular Carcinoma
    Massoud, Omar
    Charlton, Michael
    [J]. CLINICS IN LIVER DISEASE, 2018, 22 (01) : 201 - +
  • [48] Histopathological findings of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
    Kage, Masayoshi
    Aishima, Shinichi
    Kusano, Hironori
    Yano, Hirohisa
    [J]. JOURNAL OF MEDICAL ULTRASONICS, 2020, 47 (04) : 549 - 554
  • [49] Current Treatment of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
    Hung, Chun Kit
    Bodenheimer, Henry C., Jr.
    [J]. CLINICS IN LIVER DISEASE, 2018, 22 (01) : 175 - +
  • [50] Overview of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis Management
    Kim, Soo Ki
    Kim, Ke Ih
    Kim, Soo Ryang
    [J]. YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2019, 139 (09): : 1147 - 1153
12345